Context Therapeutics Inc. (CNTX)
Nasdaq: CNTX · Pharmaceutical Preparations · Philadelphia, PA · filing with the SEC since 2021
Filings
221 filings since 2017 beside 88 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 28, 2026.
Filings a yearinsider forms included
725432575143
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Jul 31, 2026.Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Jan 13, 2025.SEC letters: 4 in the last 36 months, the newest Nov 12, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Jun 26, 2026
8-K items 5.03, 5.07, 9.01
Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Jun 24, 2026
Jun 15, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
May 18, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
May 14, 2026
Apr 2, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Mar 23, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Mar 13, 2026
8-K items 5.03, 8.01, 9.01
Charter, bylaw or fiscal-year change; Other event · Current report
Mar 11, 2026
Nov 5, 2025
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
40 of 221 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.